How have RLM shares performed this year?

Realm Therapeutics' stock was trading at GBX 11.50 at the beginning of 2024. Since then, RLM stock has increased by 0.0% and is now trading at GBX 11.50. View the best growth stocks for 2024 here .

How do I buy shares of Realm Therapeutics?

Shares of RLM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

What other stocks do shareholders of Realm Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Realm Therapeutics investors own include Allena Pharmaceuticals (ALNA) , AcelRx Pharmaceuticals (ACRX) , Ampliphi Biosciences (APHB) , Viking Therapeutics (VKTX) , Arbutus Biopharma (ABUS) , Aurora Cannabis (ACBFF) and Aldeyra Therapeutics (ALDX) .

LON:RLM

Realm Therapeutics (RLM) Share Price, News & Analysis

GBX 11.50

0.00 (0.00%)

(As of 03/26/2019)

Compare

Today's Range: 11.50
▼
11.50
50-Day Range: 11.50
▼
11.50
52-Week Range: 5.80
▼
40

Volume: 169,853 shs
Average Volume: 800,861 shs
Market Capitalization: £13.40 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Realm Therapeutics alerts:

Ad Unstoppable Prosperity

“Generational Bull Run” Incoming

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.

About Realm Therapeutics

Realm Therapeutics Plc, a biopharmaceutical company, focuses on developing therapies for the treatment of immune-mediated diseases in adults and children. Its product pipeline includes PRO22, a topical gel, which is conducting initial Phase II clinical studies for the treatment of atopic dermatitis. The company was formerly known as PuriCore plc and changed its name to Realm Therapeutics Plc in December 2016. Realm Therapeutics Plc was founded in 2016 and is headquartered in Malvern, Pennsylvania.

RLM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RLM Stock News Headlines

May 23, 2024 | seekingalpha.com

EPI:CA ESSA Pharma Inc.

May 24, 2023 | washingtonpost.com

A watery mythological realm is given flesh at the Smithsonian

July 26, 2024 | Unstoppable Prosperity (Ad)

“Generational Bull Run” Incoming

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

March 23, 2023 | bbc.co.uk

Defence of the Realm Act (DORA)

February 28, 2022 | investing.com

Realm Therapeutics PLC ADR (RLM_old)

See More Headlines

Receive RLM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Realm Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:RLM
Previous Symbol: LON:PURI
CUSIP: N/A
CIK: N/A
Web: www.realmtx.com
Phone: +1-484-3212700
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 10.05
Quick Ratio: 9.96

Sales & Book Value

Annual Sales: £501,919.00
Price / Sales: 26.71
Cash Flow: GBX 20.30 per share
Price / Cash Flow: 0.57
Book Value: GBX 20.80 per share
Price / Book: 0.55

Miscellaneous

Outstanding Shares: 116,562,000
Free Float: N/A
Market Cap: £13.40 million
Optionable: Not Optionable
Beta: N/A

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. John Alexander Martin (Age 51)
CEO & Exec. Director
Ms. Marella Thorell (Age 52)
CFO, COO, Company Sec. & Exec. Director
Dr. Christian Peters (Age 57)
Chief Medical Officer

Key Competitors

View All Competitors

RLM Stock Analysis - Frequently Asked Questions

How have RLM shares performed this year?: Realm Therapeutics' stock was trading at GBX 11.50 at the beginning of 2024. Since then, RLM stock has increased by 0.0% and is now trading at GBX 11.50.
View the best growth stocks for 2024 here.
How do I buy shares of Realm Therapeutics?: Shares of RLM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What other stocks do shareholders of Realm Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some other companies that Realm Therapeutics investors own include Allena Pharmaceuticals (ALNA), AcelRx Pharmaceuticals (ACRX), Ampliphi Biosciences (APHB), Viking Therapeutics (VKTX), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF) and Aldeyra Therapeutics (ALDX).